February 22, 2016 - Speech by the President of the Republic, Dilma Rousseff, during the signing ceremony of the contract between the Ministry of Health and the Butantan Institute for the development of the dengue vaccine - São Paulo, SP.

Brazil Dilma Rousseff · President of Brazil

22 February 2016 · Signing ceremony of the contract between the Ministry of Health and the Butantan Institute for the development of the dengue vaccine · São Paulo, Brazil

Context
Rousseff addressed officials and scientists in São Paulo on February 22, 2016, at the signing of a R$100 million contract with the Butantan Institute to advance dengue vaccine trials.
Main themes
Dengue vaccine development, Butantan Institute partnership, zika virus response, chikungunya fever, public health investment, vaccine research and clinical trials, Brazil's scientific capacity, international health cooperation, government funding for science, pentavalent vaccine development, serum for zika treatment
Duration
~11 min
38th percentile
Words
1,291
38th percentile
Sentences
60
40th percentile
Readability
50
62nd percentile
Grade
11.7
41st percentile
Syntax
3.21
74th percentile
Vocabulary
2.32
77th percentile

Translated from Portuguese

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 43%43%
  • Ceremonial 42%42%
  • Environmental 7%7%
  • Institutional 5%5%
  • Geopolitical 2%2%
  • Economic 2%2%
  • Technological 0%0%
  • Not in focus 0%

60 sentences in 31 paragraphs

Good afternoon everyone.

I would like to greet the Governor of São Paulo, Geraldo Alckmin,

Greet the ministers of State who are accompanying me at this ceremony, Marcelo Castro, Minister of Health, Aldo Rebelo, Minister of Defense,

I would like to greet the Mayor of São Paulo, Fernando Haddad,

I would like to greet Alexandre Padilha, former Minister of Health,

Federal deputies Willian Woo, Marcelo Squassoni, and Fausto Pinato,

Greet Dr. David Uip, Secretary of Health of the State of São Paulo,

Mr. André Franco Montoro Filho, President of the Butantan Institute,

Dr. Jorge Kalil, Director of the Butantan Institute,

Dr. José Otávio Costa Auler Júnior, Director of the Faculty of Medicine of the University of São Paulo,

Dr. Ésper Kallas, Director of Clinical Trials at the Faculty of Medicine of USP,

I would like to greet the scientists, researchers, and professors,

Greet the journalists, photographers, and cameramen.

Today undoubtedly represents a step forward for our country. And it represents a step forward for our country because, without a doubt, the vaccine against the four serotypes of dengue is a breakthrough for Brazil.

It is a breakthrough for Brazil in two ways: first, because it will ensure a very large coverage for our population against a disease that is dengue, which affects many people. Millions of people. And, secondly, because it also affirms Brazil's role, and here the Butantan Institute deserves congratulations, as having a laboratory capable of producing a vaccine that today, without a doubt, would be used by a significant part of humanity. In short, this is an extremely auspicious moment.

Before arriving here, I witnessed the administration of the first dose to the three volunteers, the first dose of the vaccine. And as our governor said, it didn’t hurt at all. It was just a puff and the pain was gone.

But I am sure that with this, we inaugurate in Brazil, I think a very special moment, and a very special moment because we are facing a challenge. We are facing the challenge that, after all, is related to this dengue disease, but also relates to chikungunya fever and the zika virus. And it is a great satisfaction for me to be here, on behalf of the entire federal government, signing this support that we are giving to this process of developing the phase three trials of the vaccine, around R$ 100 million, which complements the other two contributions from BNDES and Finep, totaling, with the three contributions, R$ 300 million.

And, in addition, also the development of this serum that is for the treatment of those who have already contracted zika, and that would improve their situation, which we are also supporting.

So the government of São Paulo and the Butantan Institute deserve congratulations, and I think that this contract also has its support in the framework, in fact, in the new legal framework that we recently signed approving the law of the new model of support and assistance to science, technology, and innovation in Brazil. It made it possible, including, with a certain speed, this agreement.

In short, we are today facing a challenge. Brazil has strong research institutions, large laboratories, large research institutions. And Butantan, without a doubt, is one of them, and takes a very significant step with this moment that we are witnessing here today. And we have a challenge ahead of us, and for this challenge, we will take several paths. One of the paths, by the way, the challenge is to reach a vaccine against the zika virus. One of the paths is to transform this tetravalent vaccine into a pentavalent vaccine, which would also cover the dengue virus, or, as the governor said, to develop a vaccine exclusively for this purpose.

We have a set of partnerships, we have partnered with the Bio-Maguinhos Institute and the Evandro Chagas Institute, and are partnering with the University of Texas to develop a vaccine against the zika virus. We had contact with the American government and, last week, on Thursday and Friday, both the representative of the National Institutes of Health and the FDA, our equivalent of Anvisa, were there, as well as the Secretary of Health of the United States.

Tomorrow we will have a meeting with Margaret Chan, who is the Director-General of the World Health Organization. With this, we intend to have a series of paths to reach this, which is a decisive issue, which is the vaccine against the zika virus as well. And I believe that the development we signed today, which was the second signature, is something quite relevant, because it is a serum, the serum that can allow the treatment of people who have been contaminated, infected with the zika virus.

And I would like to conclude by saying that we are between this current moment and the moment when we, I am sure that the efforts of our researchers, the efforts of the great research laboratories in this country, and, just so you know, Butantan is 115 years old. It is a significant age for a young country like ours. And I would like to anticipate my congratulations to Butantan for its anniversary tomorrow, you see, Kalil.

And to say to you the following, that between this moment when we still do not have the vaccine and the moment when we have the vaccine, we must take effective action against the only way for us to try to prevent more children from being born with microcephaly and more people from having dengue, having chikungunya. And this can only be done through a process that is the extermination of the breeding sites of the mosquito, which occurs in standing water, whether dirty or clean, in various locations. But, above all, and these are data that we have as effective, it occurs in at least, in terms of where it appears, two-thirds are inside our homes, two-thirds. There are places where it reaches more than two-thirds.

I received information that, at least here in São Paulo, in the city of São Paulo, almost 80% of the breeding sites are found inside houses. That is why the campaign we have been conducting is aimed at ensuring that at least once a week, for 15 minutes, people do a clean-up regarding standing water, eliminating the breeding sites. Whether in flower pots, whether in plants, for example, bromeliads that have a place that accumulates water, whether in old tires, whether in solid waste of various kinds that range from PET bottles to bottle caps, in short, in all those places where standing water accumulates. In the panels of refrigerators, in those horizontal panels that accumulate water, in short, in all places. We ask for 15 minutes, once a week, so that we can effectively confront this virus.

We have been conducting campaigns together with state governments, and have been conducting campaigns using the Armed Forces, the Fire Department, the National Public Security Force, and, recently, we also held classes in schools.

So we ask people to make a great effort to spread the word because there is only one way between now and the vaccine and serum, to confront the zika virus, which is not to let the mosquito be born. And not letting the mosquito be born necessarily involves eliminating the breeding sites.

I thank you all, and I am sure that the mosquito, as we said in our campaign, is not stronger than the awareness of civil society, of all of us in the organized Brazilian population. Until then, we have this commitment to ourselves.

Thank you very much. It was a pleasure to be here.

And I congratulate once again the Butantan Institute for this achievement that fills our country with pride.

Thank you very much.